- Home
- FTEK vs CNTX Comparison
FTEK vs CNTX Comparison
Compare FTEK & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTEK
- CNTX
- Stock Information
- Founded
- FTEK 1987
- CNTX 2015
- Country
- FTEK United States
- CNTX United States
- Employees
- FTEK N/A
- CNTX 9
- Industry
- FTEK Pollution Control Equipment
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- FTEK Industrials
- CNTX Health Care
- Exchange
- FTEK Nasdaq
- CNTX Nasdaq
- Market Cap
- FTEK 98.7M
- CNTX 102.9M
- IPO Year
- FTEK N/A
- CNTX 2021
- Fundamental
- Price
- FTEK $2.11
- CNTX $1.11
- Analyst Decision
- FTEK Strong Buy
- CNTX Strong Buy
- Analyst Count
- FTEK 1
- CNTX 7
- Target Price
- FTEK $4.00
- CNTX $5.40
- AVG Volume (30 Days)
- FTEK 255.4K
- CNTX 440.2K
- Earning Date
- FTEK 11-04-2025
- CNTX 11-05-2025
- Dividend Yield
- FTEK N/A
- CNTX N/A
- EPS Growth
- FTEK N/A
- CNTX N/A
- EPS
- FTEK N/A
- CNTX N/A
- Revenue
- FTEK $24,713,000.00
- CNTX N/A
- Revenue This Year
- FTEK $17.16
- CNTX N/A
- Revenue Next Year
- FTEK $15.00
- CNTX N/A
- P/E Ratio
- FTEK N/A
- CNTX N/A
- Revenue Growth
- FTEK N/A
- CNTX N/A
- 52 Week Low
- FTEK $0.87
- CNTX $0.49
- 52 Week High
- FTEK $3.65
- CNTX $2.25
- Technical
- Relative Strength Index (RSI)
- FTEK 28.33
- CNTX 46.80
- Support Level
- FTEK $2.01
- CNTX $1.04
- Resistance Level
- FTEK $2.40
- CNTX $1.15
- Average True Range (ATR)
- FTEK 0.23
- CNTX 0.09
- MACD
- FTEK -0.07
- CNTX -0.03
- Stochastic Oscillator
- FTEK 21.09
- CNTX 19.70
About FTEK Fuel Tech Inc.
Fuel Tech Inc is an technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.